Triple
T11074275
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | ERBB2 |
E261825
|
entity |
| Predicate | encodes |
P14248
|
FINISHED |
| Object | NEU proto-oncogene protein |
E261824
|
NE FINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: NEU proto-oncogene protein | Statement: [ERBB2, encodes, NEU proto-oncogene protein]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: NEU proto-oncogene protein Context triple: [ERBB2, encodes, NEU proto-oncogene protein]
-
A.
PLCγ2
PLCγ2 is a phospholipase C isoform that functions as a key signaling enzyme in immune cells, mediating receptor-induced calcium mobilization and downstream activation pathways.
-
B.
Neuron
Neuron is a leading peer-reviewed scientific journal that publishes influential research in neuroscience, covering topics from molecular and cellular mechanisms to systems and cognitive neuroscience.
-
C.
Gi protein
Gi protein is a subtype of heterotrimeric G protein that inhibits adenylyl cyclase activity and modulates various intracellular signaling pathways when activated by G protein–coupled receptors.
-
D.
HER2 receptor
chosen
The HER2 receptor is a cell surface protein and member of the epidermal growth factor receptor family that, when overexpressed, drives the growth of certain aggressive breast and other cancers.
-
E.
programmed cell death protein 1
Programmed cell death protein 1 (PD-1) is an immune checkpoint receptor on T cells that downregulates immune responses and promotes self-tolerance, making it a key target in cancer immunotherapy.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Provenance (3 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d6aa9983c08190b0ef61603b69feac |
completed | April 8, 2026, 7:20 p.m. |
| NER | Named-entity recognition | batch_69d7994e32fc8190a6591d9e82b68f75 |
completed | April 9, 2026, 12:19 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69e3c8cc77988190aad54f56dbd0f8cf |
completed | April 18, 2026, 6:09 p.m. |
Created at: April 8, 2026, 9:26 p.m.